We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Actelion Warned for Failure to Report Postmarket Events
Actelion Warned for Failure to Report Postmarket Events
October 8, 2010
The FDA has requested a meeting with Actelion Pharmaceuticals’ senior management after warning the company for its failure to report postmarket adverse events, including nearly 3,500 deaths.